Spyre Therapeutics Inc (SYRE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -275,610 | -235,503 | -18,422 | -83,815 | -64,993 |
| Depreciation Amortization | 964 | 964 | 548 | 1,637 | 1,299 |
| Accounts receivable | 212 | -1,271 | 45 | 440 | 146 |
| Accounts payable and accrued liabilities | 1,001 | 2,045 | 1,384 | -2,641 | 859 |
| Other Working Capital | -3,343 | 4,608 | -1,364 | -5,503 | -4,345 |
| Other Operating Activity | 207,902 | 194,880 | 175 | 9,738 | 5,030 |
| Operating Cash Flow | $-68,874 | $-34,277 | $-17,634 | $-80,144 | $-62,004 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -91,631 | 21,000 | 17,750 | 57,046 | 43,046 |
| PPE Investments | 475 | 475 | N/A | -38 | -38 |
| Net Acquisitions | 3,035 | 3,035 | N/A | N/A | N/A |
| Other Investing Activity | 15,000 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | $-73,121 | $24,510 | $17,750 | $57,008 | $43,008 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -16 | -16 | -8 | -418 | -410 |
| Common Stock Issued | 123 | 18 | 18 | 43,096 | 43,096 |
| Other Financing Activity | 197,364 | 210,000 | 0 | 0 | 0 |
| Financing Cash Flow | $197,471 | $210,002 | $10 | $42,678 | $42,686 |
| Exchange Rate Effect | 7 | 24 | 11 | -106 | -152 |
| Beginning Cash Position | 36,416 | 36,416 | 36,416 | 16,980 | 16,980 |
| End Cash Position | 91,899 | 236,675 | 36,553 | 36,416 | 40,518 |
| Net Cash Flow | $55,483 | $200,259 | $137 | $19,436 | $23,538 |
| Free Cash Flow | |||||
| Operating Cash Flow | -68,874 | -34,277 | -17,634 | -80,144 | -62,004 |
| Capital Expenditure | N/A | N/A | N/A | -38 | -38 |
| Free Cash Flow | -68,874 | -34,277 | -17,634 | -80,182 | -62,042 |